Stanabol 50 mg Inj is a water-based stanozolol injectable manufactured by British Dragon and dosed at 50 mg/mL in a 10 mL vial.
Stanabol 50 mg Inj contains stanozolol, a synthetic anabolic-androgenic steroid derived from dihydrotestosterone. Stanozolol was originally developed in the early 1960s and was approved for medical use in the United States under the brand name Winstrol. The injectable form is presented as a micronized aqueous suspension rather than an oil-based solution, which distinguishes it from most other injectable anabolic steroids.
In medical practice, stanozolol has been used for conditions such as hereditary angioedema, aplastic anemia, and to promote weight gain in certain catabolic states. In bodybuilding and performance-enhancement settings, it is commonly referenced during cutting phases due to its ability to promote strength gains without excess water retention, and because it does not aromatize to estrogen. Non-medical use falls outside approved indications.
Stanozolol binds to androgen receptors and stimulates protein synthesis, but its effects on connective tissue and joint lubrication are distinct from many other anabolic steroids. Users frequently report joint dryness or discomfort during use, which is thought to relate to its effects on collagen and synovial fluid. Like other C17-alpha-alkylated steroids, stanozolol carries hepatotoxic potential, and its water-based suspension form may also cause more injection site discomfort than oil-based preparations.
Stanabol 50 mg Inj is formulated as a water-based suspension containing micronized stanozolol particles. This differs from oil-based injectables and requires the vial to be shaken before withdrawal to ensure even particle distribution.
Stanozolol is a synthetic anabolic steroid with a unique chemical structure and a pharmacological profile distinct from testosterone and nandrolone esters.
Stanozolol is a 17-alpha-alkylated derivative of dihydrotestosterone, a modification that allows it to survive first-pass metabolism when administered orally. The injectable form bypasses this first-pass effect but retains the compound's fundamental properties.
The biological half-life of stanozolol has been reported at approximately 24 hours. Because it is a suspension rather than a solution, its release characteristics depend on the dissolution of micronized particles at the injection site. Stanozolol does not aromatize, meaning it does not convert to estrogen, and it exhibits relatively low androgenic activity compared to testosterone.
Stanozolol is known to stimulate the production of prostaglandin E2 and matrix metalloproteinases in connective tissue, effects that may contribute to its observed impact on joint comfort and collagen metabolism.
Unlike oil-based injectables, stanozolol suspension releases the active compound as micronized particles dissolve at the injection site. This can result in a more rapid onset than oil-based preparations, with effects typically referenced as lasting approximately 24 to 48 hours.
British Dragon offers several stanozolol products in different forms and concentrations, as well as other non-aromatizing compounds commonly referenced in cutting contexts. The Stanabol 10 oral tablets provide an alternative administration route, while Mastabol 100 (drostanolone propionate) is another injectable option that does not aromatize.
For those seeking a different profile, Oxanabol (oxandrolone) is an oral compound often compared to stanozolol for its mild nature and cutting-phase use. Trenabol 100 (trenbolone acetate) is a more potent injectable sometimes referenced in advanced cutting protocols.
The information below is provided for educational reference only. Stanozolol is a controlled anabolic steroid; medical use requires appropriate diagnosis and clinical supervision. Non-medical use falls outside approved indications.
In medically supervised settings, injectable stanozolol has been administered at 50 mg every 2 to 3 weeks for specific indications. In non-medical bodybuilding contexts, stanozolol is commonly referenced in the range of 25–100 mg per day for men, with 50 mg per day frequently cited as a typical dose. Women are generally referenced at lower doses, commonly 5–10 mg per day, to minimize virilization risk.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| Medical (injectable) | 50 mg every 2–3 weeks | Per clinical protocol |
| Bodybuilding (non-medical, men) | 25–100 mg / day | Daily or every other day |
| Bodybuilding (non-medical, women) | 5–10 mg / day | Daily |
In non-medical bodybuilding contexts, stanozolol is frequently used during cutting cycles and may be combined with other non-aromatizing compounds. It is sometimes stacked with testosterone at a lower dose to maintain hormonal balance, though stanozolol itself does not aromatize. British Dragon offers several products commonly referenced in cutting contexts, including T3 and Clenbuterol.
Because stanozolol is a C17-alpha-alkylated steroid, combining it with other hepatotoxic compounds may increase liver stress. Cycle duration and total exposure are important considerations.
Stanozolol can suppress endogenous testosterone production, and post-cycle recovery support may be considered after use. Joint dryness or discomfort is commonly reported and may be managed by adjusting training volume or considering joint support measures.
As a C17-alpha-alkylated steroid, stanozolol carries hepatotoxic potential. Liver function monitoring is advisable during use, particularly with oral administration or prolonged cycles. Lipid profile changes, including reduced HDL cholesterol, have also been associated with anabolic steroid use generally.
After completing a cycle with Stanabol 50 mg Inj, post-cycle therapy may be considered to support restoration of endogenous testosterone production. Agents such as Clomiphene and Tamoxifen are commonly referenced for this purpose in bodybuilding contexts.
PCT protocols vary based on cycle length, compounds used, and individual factors. Bloodwork can help inform recovery strategy.
Dosing strategies, support compounds, and recovery protocols should be adjusted based on experience level and individual factors. The information above is for educational reference and does not constitute medical advice.
Stanozolol is an anabolic steroid that can affect hepatic, cardiovascular, and endocrine function. Medical use requires appropriate diagnosis, clinical supervision, and ongoing monitoring.
Stanozolol is a controlled anabolic steroid and is not approved for bodybuilding or performance enhancement in healthy individuals. Medical use has been limited to specific conditions such as hereditary angioedema and certain anemias.
Stanozolol can suppress natural testosterone production, which may affect fertility and hormonal balance. Individual risk depends on dose, duration, health status, and other factors.
Anabolic steroid use for physique or performance enhancement is not medically approved. Product concentration and laboratory verification do not establish that non-medical use is safe or appropriate for an individual.
Serious and even fatal cases of liver problems have developed during treatment with stanozolol. Early signs include abdominal pain, light-colored stools, dark-colored urine, unusual fatigue, nausea, or yellowing of the skin or eyes.
Endogenous testosterone suppression is expected with exogenous anabolic steroid use. This can lead to reduced sperm production and testicular atrophy during use. Recovery of natural hormone production after discontinuation varies by individual and cycle characteristics.
Androgenic effects such as acne, oily skin, and hair loss in predisposed individuals can occur. Women may experience virilization symptoms including voice deepening, clitoral enlargement, and menstrual irregularities, particularly at higher doses.
Stanozolol is not appropriate for individuals with certain medical conditions. Medical evaluation should precede any consideration of use, particularly for those with existing liver disease, cardiovascular conditions, prostate issues, or a history of hormone-sensitive cancers.
Pregnancy and breastfeeding are absolute contraindications. Women considering use should be aware of the potential for irreversible virilization effects.
Medically supervised anabolic steroid therapy involves regular monitoring of liver function, lipid profiles, and hormone levels. Hematocrit and blood pressure should also be assessed. Non-medical use typically lacks this monitoring, increasing the risk of unrecognized adverse effects.
Keep the vial securely stored and protected from conditions that could compromise the product or container. Shake the vial gently before withdrawal to ensure even particle distribution. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated, or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Stanabol 50 mg Inj is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official British Dragon distribution chain.
To verify your Stanabol 50 mg Inj product, use the security features on the vial label and cross-check them with official British Dragon presentation. Genuine British Dragon vials typically feature specific label characteristics and packaging details that distinguish them from counterfeits.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the aqueous suspension.
Keep the vial in its original packaging until use. Do not freeze. Before administration, shake the vial gently to ensure even particle distribution and inspect the solution. Avoid use if it appears discolored, contains clumps that do not disperse, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Stanabol 50 mg Inj, stanozolol, usage, and related topics.
Stanabol 50 mg Inj contains stanozolol, an anabolic steroid. In medical practice, stanozolol has been used for conditions such as hereditary angioedema and certain types of anemia. In non-medical bodybuilding settings, Stanabol 50 mg Inj is commonly referenced during cutting phases for strength and muscle preservation, though such use falls outside approved medical indications.
In medical settings, injectable stanozolol has been administered at 50 mg every 2 to 3 weeks. In non-medical bodybuilding contexts, daily or every-other-day injection is commonly referenced to maintain serum levels, with some users preferring daily administration.
Stanozolol can suppress endogenous testosterone production. In non-medical bodybuilding contexts, post-cycle therapy is commonly referenced after a Stanabol cycle to support hormonal recovery. Agents such as Clomiphene and Tamoxifen are commonly discussed for this purpose.
Stanozolol binds to androgen receptors and stimulates protein synthesis in muscle tissue. It is a 17-alpha-alkylated steroid derived from dihydrotestosterone and does not aromatize to estrogen. Its effects on connective tissue and joint lubrication are distinct from many other anabolic steroids, and joint dryness is commonly reported.
The biological half-life of stanozolol has been reported at approximately 24 hours. Because the injectable form is a suspension, release characteristics depend on the dissolution of micronized particles at the injection site. Visible effects on physique and performance are typically referenced as taking several weeks to become apparent, depending on dose, diet, training, and individual factors.
There is no single cutting compound that is universally best. Stanozolol is often described as having a mild side effect profile relative to other anabolic steroids, but it is still a controlled anabolic steroid with potential adverse effects, including hepatotoxicity and joint discomfort. Its suitability depends on individual goals, risk tolerance, and other factors.
Both stanozolol and oxandrolone are oral or injectable anabolic steroids commonly referenced in cutting contexts. Stanozolol is a 17-alpha-alkylated DHT derivative, while oxandrolone is a different compound with its own profile. British Dragon offers Oxanabol (oxandrolone) as an alternative often compared to stanozolol for its mild nature.
Stanozolol is a 17-alpha-alkylated steroid administered orally or as an aqueous suspension, while drostanolone is typically administered as an oil-based ester such as propionate or enanthate. Both are non-aromatizing compounds commonly referenced in cutting phases. British Dragon offers Mastabol 100 (drostanolone propionate) as an injectable alternative.
A milligram amount cannot be classified as appropriate or excessive without considering individual factors, experience level, and goals. In bodybuilding contexts, 50 mg per day falls within commonly referenced ranges for men, but this does not establish that it is safe or appropriate for any individual. Non-medical use falls outside approved indications.
Stanabol 50 mg Inj is labeled at 50 mg of stanozolol per mL. It is supplied in a 10 mL vial, giving 500 mg of total labeled stanozolol content per vial.
No. Stanozolol does not aromatize to estrogen, meaning it is not associated with estrogenic side effects such as gynecomastia or water retention. This characteristic distinguishes it from testosterone-based compounds.